medigraphic.com
ISSN 0210-5187 (Electronic)

2015, Number 3

<< Back Next >>

Med Cutan Iber Lat Am 2015; 43 (3)

Cutaneous leishmaniasis. A case with good response to fluconazole

Gaudiano G, Valderrama AM, Avila CJ

Language: Spanish
References: 10
Page: 226-228
PDF size: 458.57 Kb.


ABSTRACT

Meglumine antimonate is the treatment in our setting, for cutaneous leishmaniasis. We report a 62 years old patient with cutaneous leishmaniasis, reluctant to treatment with meglumine that course with excellent response to oral fluconazole.


REFERENCES

  1. Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In: Peters W, Killick-Kendrick R et al. The leishmaniases in biology and medicine. London: Academic Press; 1987, pp. 1-120.

  2. Pearson RD, Sousa AQ. Clinical spectrum of leishmaniasis. Clin Infect Dis. 1996; 22: 1-13.

  3. Pérez ME, Izquierdo R, Montalbán E, Hernández R, Verne E. Leishmaniasis Cutánea. Hospital Universitaria Pía del Río Hortega, Valladolid, España. J Anpedi. 2009, pp. 154-156.

  4. Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med. 2002; 346: 891-895.

  5. Morizot G, Delgiudice P, Caumes E et al. Healing of old world cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution? Am J Trop Med Hyg. 2007; 76: 48-52.

  6. Sousa AQ, Frutuoso MS, Moraes EA, Pearson RD, Pompeu MM. High-dose oral fluconazole therapy effective for cutaneous leishmaniasis due to leishmania (Vianna) braziliensis. Clin Infect Dis. 2011; 53 (7): 693-695.

  7. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med. 1994; 330: 263-272.

  8. Malik A. Origin of drugs in current use: the Diflucan story. 2001. Available at: http://www.world-offungi.org/Mostly_Medical/Abrar_Malik/Abrar_Malik.htm.

  9. Emad M, Hayati F, Fallahzadeh MK, Namazi MR. Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: a randomized clinical trial. J Am Acad Dermatol. 2011; 64: 606-608.

  10. Menichetti F, Fiorio M, Tosti A et al. High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS. Clin Infect Dis. 1996; 22: 838-840.




2020     |     www.medigraphic.com